Intravitreal administration of recombinant human opticin protects against hyperoxia-induced pre-retinal neovascularization

Izabela P. Klaska, Anne White, Pilar Villacampa, Justin Hoke, Laura Abelleira-Hervas, Ryea N. Maswood, Robin R. Ali, Catey Bunce, Richard D. Unwin, Garth J.S. Cooper, Paul N. Bishop, James W. Bainbridge*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

Opticin is an extracellular glycoprotein present in the vitreous. Its antiangiogenic properties offer the potential for therapeutic intervention in conditions such as proliferative diabetic retinopathy and retinopathy of prematurity. Here, we investigated the hypothesis that intravitreal administration of recombinant human opticin can safely protect against the development of pathological angiogenesis and promote its regression. We generated and purified recombinant human opticin and investigated its impact on the development and regression of pathological retinal neovascularization following intravitreal administration in murine oxygen-induced retinopathy. We also investigated its effect on normal retinal vascular development and function, following intravitreal injection in neonatal mice, by histological examination and electroretinography. In oxygen-induced retinopathy, intravitreal administration of human recombinant opticin protected against the development of retinal neovascularization to similar extent as aflibercept, which targets VEGF. Opticin also accelerated regression of established retinal neovascularization, though the effect at 18 h was less than that of aflibercept. Intravitreal administration of human recombinant opticin in neonatal mice caused no detectable perturbation of subsequent retinal vascular development or function. In summary we found that intraocular administration of recombinant human opticin protects against the development of pathological angiogenesis in mice and promotes its regression.

Original languageEnglish
Article number108908
JournalExperimental Eye Research
Volume215
DOIs
Publication statusPublished - Feb 2022

Keywords

  • Angiogenesis
  • Neovascularization
  • OIR
  • Opticin
  • PDR
  • ROP

Fingerprint

Dive into the research topics of 'Intravitreal administration of recombinant human opticin protects against hyperoxia-induced pre-retinal neovascularization'. Together they form a unique fingerprint.

Cite this